Schelomo Marmor

Picture of Schelomo Marmor
Associate Professor
Surgical Oncology
Co-Director
Center for Quality Outcomes, Discovery and Evaluation (C-QODE)
Biography

Dr. Marmor is an Associate Professor in the Department of Surgery, Division of Surgical Oncology at the University of Minnesota Medical School. He also serves as the founding Co-Director of the Center of Quality Outcomes Delivery and Evaluation (C-QODE), a Center that provides Medical School investigators with a data platform for researchers accessing electronic health records, administrative data and public use files for research, with a particular emphasis on helping researchers understand the strengths, weaknesses and applications of the data. His work and multidisciplinary approach supports his collaborators in their effort to improve clinical quality and outcomes. 

Dr. Marmor specializes in bridging the gap between vast amounts of data and healthcare outcomes. He particularly focuses on oncological outcomes. He leads collaborations to mine consequential insights from data and works across multidisciplinary clinical research teams. His research expertise supports a wide breadth of verticals in the health industry, including Health Services Research, Healthcare Outcomes, Oncological Outcomes, Health Care Costs and Financing, Healthcare Policy and Insights, Center for Medicare and Medicaid Services (CMS) Payment Models, and the Medical Device Industry. As part of his work for C-QODE, he supports clinical investigators interested in using data to answer clinical questions. He has used administrative big data for other projects as well in oncology and the overuse of imaging in Medicare and Medicare Advantage patients. His work focuses on encouraging guideline concordant care, minimizing geographic and racial disparities, the improvement of clinical quality and patient outcomes. His team science principles have led to multidisciplinary research initiatives that have received national recognition. His research leads to the development of new treatments for patients suffering from cancer and other chronic conditions and contribute to the long-term public health.